Lazard Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $287M | Sell |
3,309,161
-102,641
| -3% | -$9.83M | 0.47% | 52 |
|
|
2025
Q4 | $328M | Sell |
3,411,802
-2,589,540
| -43% | -$252M | 0.56% | 41 |
|
|
2025
Q3 | $572M | Buy |
6,001,342
+957,149
| +19% | +$88M | 0.77% | 30 |
|
|
2025
Q2 | $440M | Buy |
5,044,193
+377,068
| +8% | +$32M | 0.61% | 40 |
|
|
2025
Q1 | $419M | Sell |
4,667,125
-2,408,006
| -34% | -$215M | 0.64% | 40 |
|
|
2024
Q4 | $565M | Sell |
7,075,131
-315,549
| -4% | -$27.3M | 0.83% | 29 |
|
|
2024
Q3 | $665M | Buy |
7,390,680
+2,270,202
| +44% | +$191M | 0.89% | 32 |
|
|
2024
Q2 | $403M | Sell |
5,120,478
-166,957
| -3% | -$13.7M | 0.51% | 48 |
|
|
2024
Q1 | $461M | Sell |
5,287,435
-515,272
| -9% | -$44M | 0.56% | 47 |
|
|
2023
Q4 | $478M | Buy |
5,802,707
+439,004
| +8% | +$33.5M | 0.6% | 42 |
|
|
2023
Q3 | $420M | Sell |
5,363,703
-1,108,259
| -17% | -$92.8M | 0.57% | 44 |
|
|
2023
Q2 | $570M | Buy |
6,471,962
+802,936
| +14% | +$69.1M | 0.7% | 39 |
|
|
2023
Q1 | $457M | Sell |
5,669,026
-1,414,623
| -20% | -$115M | 0.6% | 43 |
|
|
2022
Q4 | $551M | Sell |
7,083,649
-6,831,068
| -49% | -$554M | 0.76% | 30 |
|
|
2022
Q3 | $1.12B | Sell |
13,914,717
-2,233,182
| -14% | -$201M | 1.64% | 8 |
|
|
2022
Q2 | $1.45B | Sell |
16,147,899
-5,913,815
| -27% | -$599M | 1.96% | 5 |
|
|
2022
Q1 | $2.45B | Sell |
22,061,714
-3,308,609
| -13% | -$350M | 2.84% | 3 |
|
|
2021
Q4 | $2.62B | Buy |
25,370,323
+1,196,593
| +5% | +$139M | 2.79% | 3 |
|
|
2021
Q3 | $3.03B | Sell |
24,173,730
-425,110
| -2% | -$55M | 3.42% | 3 |
|
|
2021
Q2 | $3.05B | Buy |
24,598,840
+410,663
| +2% | +$51.6M | 3.43% | 3 |
|
|
2021
Q1 | $2.86B | Buy |
24,188,177
+151,977
| +0.6% | +$17.8M | 3.46% | 2 |
|
|
2020
Q4 | $2.82B | Sell |
24,036,200
-258,365
| -1% | -$28.4M | 3.56% | 1 |
|
|
2020
Q3 | $2.52B | Sell |
24,294,565
-120,386
| -0.5% | -$12.1M | 3.55% | 2 |
|
|
2020
Q2 | $2.24B | Sell |
24,414,951
-1,280,656
| -5% | -$123M | 3.44% | 2 |
|
|
2020
Q1 | $2.32B | Sell |
25,695,607
-3,016,985
| -11% | -$321M | 4.25% | 1 |
|
|
2019
Q4 | $3.26B | Buy |
28,712,592
+551,029
| +2% | +$60.5M | 4.65% | 1 |
|
|
2019
Q3 | $3.06B | Buy |
28,161,563
+95,274
| +0.3% | +$9.94M | 5.03% | 1 |
|
|
2019
Q2 | $2.73B | Buy |
28,066,289
+241,438
| +0.9% | +$22M | 4.43% | 1 |
|
|
2019
Q1 | $2.53B | Buy |
27,824,851
+1,966,733
| +8% | +$176M | 4.15% | 1 |
|
|
2018
Q4 | $2.35B | Sell |
25,858,118
-76,435
| -0.3% | -$7.14M | 4.33% | 1 |
|
|
2018
Q3 | $2.55B | Sell |
25,934,553
-2,111,503
| -8% | -$195M | 4.13% | 1 |
|
|
2018
Q2 | $2.4B | Buy |
28,046,056
+124,570
| +0.4% | +$10.4M | 4.17% | 1 |
|
|
2018
Q1 | $2.24B | Buy |
27,921,486
+2,081,883
| +8% | +$172M | 3.82% | 1 |
|
|
2017
Q4 | $2.09B | Buy |
25,839,603
+72,232
| +0.3% | +$5.78M | 3.57% | 1 |
|
|
2017
Q3 | $2B | Buy |
25,767,371
+3,391,398
| +15% | +$282M | 3.63% | 1 |
|
|
2017
Q2 | $1.99B | Buy |
22,375,973
+6,713,647
| +43% | +$566M | 3.73% | 1 |
|
|
2017
Q1 | $1.26B | Buy |
15,662,326
+14,484,546
| +1,230% | +$1.13B | 2.38% | 2 |
|
|
2016
Q4 | $83.9M | Sell |
1,177,780
-19,320
| -2% | -$1.52M | 0.17% | 98 |
|
|
2016
Q3 | $103M | Buy |
1,197,100
+36,769
| +3% | +$3.2M | 0.21% | 93 |
|
|
2016
Q2 | $101M | Buy |
1,160,331
+434,918
| +60% | +$35.2M | 0.21% | 99 |
|
|
2016
Q1 | $54.4M | Buy |
725,413
+315,951
| +77% | +$23.8M | 0.12% | 143 |
|
|
2015
Q4 | $31.5M | Buy |
409,462
+245,400
| +150% | +$18.5M | 0.07% | 188 |
|
|
2015
Q3 | $11M | Buy |
164,062
+161,400
| +6,063% | +$11.9M | 0.03% | 351 |
|
|
2015
Q2 | $196K | Sell |
2,662
-5,135
| -66% | -$392K | ﹤0.01% | 846 |
|
|
2015
Q1 | $608K | Sell |
7,797
-834
| -10% | -$63.2K | ﹤0.01% | 742 |
|
|
2014
Q4 | $622K | Sell |
8,631
-6,265
| -42% | -$435K | ﹤0.01% | 801 |
|
|
2014
Q3 | $921K | Buy |
14,896
+12,375
| +491% | +$787K | ﹤0.01% | 692 |
|
|
2014
Q2 | $160K | Sell |
2,521
-300
| -11% | -$18.2K | ﹤0.01% | 875 |
|
|
2014
Q1 | $173K | Buy |
2,821
+301
| +12% | +$17.5K | ﹤0.01% | 837 |
|
|
2013
Q4 | $143K | Buy |
2,520
+520
| +26% | +$29.5K | ﹤0.01% | 850 |
|
|
2013
Q3 | $106K | Sell |
2,000
-190
| -9% | -$10.2K | ﹤0.01% | 831 |
|
|
2013
Q2 | $112K | Buy |
+2,190
| New | +$108K | ﹤0.01% | 871 |
|
Other funds holding MDT
VCM
VPM
Lazard Asset Management's MDT Position: Q1 2026 in Review
Lazard Asset Management reduced its Medtronic (MDT) stake by 3% in Q1 2026, selling an estimated $9.83M and leaving 3,309,161 shares worth $287M. The position accounts for 0.47% of the portfolio, ranked #52.
Lazard Asset Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.26B in Q4 2019. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Lazard Asset Management held 3,309,161 shares of Medtronic worth $287M as of Q1 2026.
- Lazard Asset Management sold 102,641 Medtronic shares in Q1 2026, an estimated $9.83M.
- Medtronic made up 0.47% of Lazard Asset Management's portfolio in Q1 2026, its #52 holding.
- Lazard Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- Lazard Asset Management's Medtronic position peaked at $3.26B in Q4 2019.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.